Our data are in agreement with the previous reports showing that high affinity ApoA-I and ApoE to low-density lipoprotein (LDLR) and HDL receptors, which are overexpressed in liver cancer cells, could be used to target HCC [100,101,102]. The gene discussed is LDLR; the disease is liver cancer.